Teladoc Health Files Q1 2025 10-Q
Ticker: TDOC · Form: 10-Q · Filed: 2025-05-01T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, quarterly-report
TL;DR
TDOC Q1 2025 10-Q filed. Financials updated.
AI Summary
Teladoc Health, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details the company's financial position and operational performance during the first quarter of 2025. Key financial data and disclosures relevant to investors are presented in this report.
Why It Matters
This filing provides investors with the latest financial performance and health of Teladoc Health, Inc., crucial for understanding its current market standing and future prospects.
Risk Assessment
Risk Level: medium — 10-Q filings are standard financial reports, but the specific financial health and market conditions of Teladoc Health can introduce medium-level risk.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the end of the fiscal quarter covered by the report.)
- 2025-05-01 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
- 2024-12-31 — Prior Period End Date (Provides a comparison point for financial data from the end of the previous fiscal year.)
Key Players & Entities
- Teladoc Health, Inc. (company) — Filer of the 10-Q report
- 20250331 (date) — End of the reporting period
- 20250501 (date) — Filing date of the report
- 0001477449 (company) — Central Index Key for Teladoc Health, Inc.
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the quarter ended March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 1, 2025.
What is the company's Central Index Key (CIK)?
The Central Index Key for Teladoc Health, Inc. is 0001477449.
What was the previous period end date mentioned in the filing data?
The previous period end date mentioned is December 31, 2024.
What is the company's primary business address?
The company's business address is 2 Manhattanville Road, Suite 203, Purchase, NY 10577.
From the Filing
0001477449-25-000049.txt : 20250501 0001477449-25-000049.hdr.sgml : 20250501 20250501162922 ACCESSION NUMBER: 0001477449-25-000049 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 87 CONFORMED PERIOD OF REPORT: 20250331 FILED AS OF DATE: 20250501 DATE AS OF CHANGE: 20250501 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Teladoc Health, Inc. CENTRAL INDEX KEY: 0001477449 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 043705970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-37477 FILM NUMBER: 25903701 BUSINESS ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 BUSINESS PHONE: 2036352002 MAIL ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 FORMER COMPANY: FORMER CONFORMED NAME: Teladoc, Inc. DATE OF NAME CHANGE: 20091123 10-Q 1 tdoc-20250331.htm 10-Q tdoc-20250331 0001477449 2025 --12-31 Q1 false 9 1 http://www.teladoc.com/20250331#AccruedLiabilitiesAndOtherLiabilitiesExcludingAccruedCompensationCurrent http://www.teladoc.com/20250331#AccruedLiabilitiesAndOtherLiabilitiesExcludingAccruedCompensationCurrent 0.0041258 0.0186621 0.01394 P1Y P1Y http://www.teladoc.com/20250331#AccruedLiabilitiesAndOtherLiabilitiesExcludingAccruedCompensationCurrent P2Y P3Y P3Y xbrli:shares iso4217:USD iso4217:USD xbrli:shares tdoc:professional_association tdoc:professional_corporation xbrli:pure tdoc:segment tdoc:debt_series tdoc:day 0001477449 2025-01-01 2025-03-31 0001477449 2025-04-24 0001477449 2025-03-31 0001477449 2024-12-31 0001477449 2024-01-01 2024-03-31 0001477449 us-gaap:CommonStockMember 2024-12-31 0001477449 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001477449 us-gaap:RetainedEarningsMember 2024-12-31 0001477449 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001477449 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001477449 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001477449 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0001477449 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001477449 us-gaap:CommonStockMember 2025-03-31 0001477449 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001477449 us-gaap:RetainedEarningsMember 2025-03-31 0001477449 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001477449 us-gaap:CommonStockMember 2023-12-31 0001477449 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001477449 us-gaap:RetainedEarningsMember 2023-12-31 0001477449 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001477449 2023-12-31 0001477449 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001477449 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001477449 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001477449 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001477449 us-gaap:CommonStockMember 2024-03-31 0001477449 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001477449 us-gaap:RetainedEarningsMember 2024-03-31 0001477449 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001477449 2024-03-31 0001477449 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2025-01-01 2025-03-31 0001477449 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2024-01-01 2024-03-31 0001477449 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2025-03-31 0001477449 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2024-12-31 0001477449 tdoc:SubscriptionAccessFeesMember 2025-01-01 2025-03-31 0001477449 tdoc:SubscriptionAccessFeesMember 2024-01-01 2024-03-31 0001477449 tdoc:OtherRevenueMember 2025-01-01 2025-03-31 0001477449 tdoc:OtherRevenueMember 2024-01-01 2024-03-31 0001477449 country:US 2025-01-01 2025-03-31 0001477449 country:US 2024-01-01 2024-03-31 0001477449 us-gaap:NonUsMember 2025-01-01 2025-03-31 000147